Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32011 total
Disc Medicine heads into the final week of August with a striking disconnect: the stock has climbed 11% over the past month while the CEO has been consistently selling into that strength. The insider angle is the most…
The Amundi Core MSCI Emerging Markets UCITS ETF (AEMD) heads into the final week of August with its most notable story sitting in the lending market rather than the underlying index — borrowing costs have roughly…
Why this matters: Cisco Systems is sending mixed signals. Options traders are loading up on puts. Short sellers are exiting. Both moves accelerated this week — and the divergence is worth watching. The put-call ratio…
Federal Reserve Governor Kevin Warsh rattled markets Thursday. His comments revived rate hike bets and sent the Nasdaq 100 lower. Strategy Inc fell more than 7% as Bitcoin pulled back sharply. Coinbase and Affirm were…
Hundreds of companies report this week. Today alone brings a wave of major names across Asia, Europe, and North America. BYD — the world's largest electric vehicle maker — releases results today. The Chinese auto giant…
Workday dominated analyst activity Thursday, with three firms raising price targets after strong earnings. Barclays lifted its target to $224 from $200. Citigroup moved to $201 from $139. Stifel went to $160 from $115.…
Bill Gates has been quietly building a massive position in RSG. Filings show he bought over $561M in Republic Services shares across 44 transactions this month. He paid an average of roughly $218 per share. The buying…
Citigroup just delivered a sharp reassessment of FINV. Analyst Judy Zhang downgraded FinVolution Group from Buy to Neutral and slashed the price target 49% — from $8.10 to $4.10. The stock closed at $4.02 on August 27,…
Short sellers made bold moves this week. Capricor Therapeutics saw the biggest jump. Its short interest hit 45.6% of free float — up 9.2 percentage points in just seven days. That is a sharp, sudden build from bears…
Institutional money made a sharp turn this week. The US — the world's largest ETF market — saw a net outflow of $24.2B over the past seven days. That reverses a 3-month trend where US-focused funds pulled in $357.5B.…
Two days ago, PTF availability sat at 74%. Today it has loosened back to 111% — but the cost to borrow just broke 10%. The divergence between those two data points is the story. The borrow rate on the Invesco Dorsey…
Why this matters: Three distinct signals on XLB are now pointing the same direction. Short sellers are retreating. Options traders are loading up on calls. Yet the cost to borrow is climbing — a notable contradiction…
PYPL dropped sharply today after reports emerged that Advent International and Stripe abandoned their joint $50 billion takeover bid. The deal collapse removes a key near-term catalyst for the payments giant. Short…
Over 400 companies report this week. The calendar is busiest today, Friday August 28, with key names crossing multiple regions. BeOne Medicines AG headlines today's US-listed action. The $42.7 billion oncology firm…
WDAY took the sharpest blow Thursday. The consensus rating slipped to a downgrade. One analyst cut their hold count. Needham's Scott Berg went the other way, raising his target sharply to $230 from $180 — a $50 jump…
Board members at ILMN have filed a wave of sell orders worth over $200 million in August. Keith Meister and his firm Corvex Management filed multiple tranches of sales this week alone. Meister filed $33M in sales on…
Short sellers are making big moves this week. Data as of August 27 shows sharp shifts in both directions across US markets. CAPR tops the week's biggest short interest builds. Capricor Therapeutics saw its SI % of free…
Six analyst firms raised their price targets on Revolution Medicines on Wednesday alone. That wall of upgrades is the defining story here — and the rest of the data is moving in the same direction. Oppenheimer, RBC…
Options positioning in Loews has hit a 52-week extreme. Short sellers, meanwhile, are heading for the exit. The two signals pull in opposite directions — and that tension is the story. The put-call ratio has climbed to…
ASST has now climbed 43% in a week and 90% over the past month. The borrow market has not loosened to match — it has done the opposite. Availability has dropped to 6%. That means roughly one share remains available for…
